D-1535-2020 Class II Terminated
FDA drug recall D-1535-2020 was initiated by Aurobindo Pharma USA Inc. on Aug 10, 2020 and is designated Class II. Reason for recall: Presence of Foreign Substance: product complaints were received by the firm for the presence of metal wire in the tablet(s). The recall status is terminated (terminated Jun 28, 2024). Affected quantity: 5748 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 2, 2020
- Initiation Date
- Aug 10, 2020
- Termination Date
- Jun 28, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 5748 bottles
Product description
Sulfamethoxazole and Trimethoprim Tablets, USP, 800 mg/160 mg Double Strength, 500 Tablets per bottle, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India, NDC: 65862-420-05.
Reason for recall
Presence of Foreign Substance: product complaints were received by the firm for the presence of metal wire in the tablet(s).
Distribution pattern
Nationwide in the U.S.
Code information
Lot #s: STSD19109-A, Exp. 05/31/2022; SP1D19083AA3, SP1D19084AA3, Exp. 08/31/2022.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1535-2020
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026